Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Obesity × Dalteparin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1 Classical hematology 1

Conditions

Venous Thromboembolism 13 Venous Thrombosis 10 Neoplasms 9 Pulmonary Embolism 7 Thromboembolism 4 Thrombosis 3 Pancreatic Neoplasms 3 Multiple Myeloma 3 Lung Neoplasms 3 Neoplasm Metastasis 2 Lymphoma 2 Colorectal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Uterine Cervical Neoplasms 1 Thrombocytopenia 1 Thrombocythemia, Essential 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Primary Myelofibrosis 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Precancerous Conditions 1 Ovarian Neoplasms 1 Obesity 1 Neoplasms, Plasma Cell 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1 Monoclonal Gammopathy of Undetermined Significance 1

Interventions

Exercise 22 Metformin 18 Tirzepatide 8 Diet 8 Nutrition Assessment 7 Methods 7 Diet Therapy 7 Counseling 7 Resistance Training 6 Early Intervention, Educational 6 Caloric Restriction 6 semaglutide 5 Exenatide 5 Diet, Mediterranean 5 Blood Specimen Collection 5 Surveys and Questionnaires 4 Liraglutide 4 Educational Status 4 Docosahexaenoic Acids 4 Bariatric Surgery 4 exemestane 3 Vitamin D 3 Tamoxifen 3 Standard of Care 3 Observation 3 Naltrexone 3 Dexamethasone 3 Bupropion 3 bupropion hydrochloride, naltrexone hydrochoride drug combination 2 Yoga 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03297359 2024-01-23

WAVe

Ottawa Hospital Research Institute

Phase 2 Terminated

Classical hematologyOther

Neoplasms, Obesity, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡